Neoplasm Risk in Patients With Rheumatoid Arthritis Treated With Fostamatinib: A Systematic Review and Meta-analysis

Objective: This study aimed to assess neoplasm risk in patients with rheumatoid arthritis (RA) treated with fostamatinib. Methods: Studies were collected from electronic databases of OVID Medline, OVID EMBASE, Cochrane Central Register of Controlled Trials, and Web of Science. We included studies th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuehong, Liu, Huan, Tian, Yunru, Luo, Zhongling, Yin, Geng, Xie, Qibing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926144/
https://www.ncbi.nlm.nih.gov/pubmed/35308252
http://dx.doi.org/10.3389/fphar.2022.768980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926144/
https://www.ncbi.nlm.nih.gov/pubmed/35308252
http://dx.doi.org/10.3389/fphar.2022.768980

Ejemplares similares